期刊文献+

海普诺改善HepG2细胞胰岛素抵抗作用研究 被引量:3

HPN improves insulin resistance of HepG2 cells
下载PDF
导出
摘要 通过细胞形态观察和CCK-8法研究HPN对HepG2细胞活力的影响。采用高糖高浓度胰岛素持续作用诱导 HepG2细胞建立胰岛素抵抗细胞模型,用多功能自动生化仪葡萄糖-己糖激酶法检测海普诺(HPN)对正常HepG2细胞及胰岛素抵抗HepG2细胞葡萄糖消耗量的影响。实验结果显示,低浓度的HPN对HepG2细胞增殖没有影响。HPN与胰岛素协同作用HepG2细胞,低浓度胰岛素对葡萄糖利用有一定的促进作用;当胰岛素浓度为1×10^–6 mol/L时, HPN可明显促进HepG2细胞葡萄糖消耗。进一步研究表明, HPN在5×10^–8~1×10^–7 mol/L浓度范围内可明显促进胰岛素抵抗HepG2细胞的葡萄糖的消耗。HPN可明显改善HepG2细胞胰岛素抵抗。 The effect of HPN on viability of HepG2 cells was determined by cell morphology and CCK8 assay. In-sulin resistant HepG2 cell model was established by continuously treating cells with high concentrations of glucose and insulin. The glucose consumption was determined by multi-functional automatic glucose-hexokinase method. The results showed that HPN had no effect on proliferation of HepG2 cells at low concentrations., The glucose consumption of HepG2 cells was improved by HPN when collaborating with a low concentration of insulin. When the insulin concentration increased to 1×10^–6 mol/L, the HPN can markedly increase the glucose consumption of HepG2 cells.HPN can greatly enhance the glucose consumption in the insulin resistant cells with a concentration range of 5×10^–8 mol/L to 1×10^–7 mol/L. Therefore, HPN can significantly improve insulin resistance.
出处 《海洋科学》 CAS CSCD 北大核心 2015年第3期26-32,共7页 Marine Sciences
基金 国家自然科学基金项目(NO.41276167,NO.41206066) 青岛市市南区科技发展资金项目(NO.2012-5-007-SW)
关键词 海普诺 胰岛素抵抗 HEPG2细胞 HPN insulin resistance HepG2 cell
  • 相关文献

参考文献21

  • 1Cordain L, Eades M R, Eades M D. Hyperinsulinemic diseases of civilization: more than just Syndrome X[J]. Comp BiochemPhysiol A MollnteqrPhysiol, 2003, 136(1): 95-112.
  • 2Kopelman P. The metabolic syndrome as a clinical problem[J]. Nestle Nutr Workshop Ser Clin Perform,2004, 9: 77-88.
  • 3Yang W Y, Lu J M, Weng J P, et al. Prevalence of diabetes among men and women in China[J]. New England Journal of Medicine, 2010, 362:1090-1101.
  • 4Shi D Y, Guo S J, Jiang B, et al. HPN, a Synthetic Analogue of Bromophenol from Red Alga Rhodomela confervoides: Synthesis and Anti-Diabetic Effects in C57BL/KsJ-db/db Mice[J]. Mar Drugs, 2013, 11: 350-362.
  • 5Yin J, Hu R, Chen M, et al. Effects of Berberine on Glucose Metabolism In Vitro[J]. Metabolism, 2002, 15: 1439-1443.
  • 6Lovatil M R.Manzoni C, Castiglioni S, et al. Lupin seed γ-conglutin lowers blood glucose in hyper glycaemic rats and increases glucose consumption of HepG2 cells [J]. British Journal of Nutrition, 2011, 107 67-73.
  • 7陈秋,夏永鹏,邱宗荫.吡格列酮对胰岛素抵抗HepG2细胞模型的药理学评价[J].中国药理学通报,2006,22(2):248-251. 被引量:33
  • 8刘晓海,董志,傅洁民,曾凡新.倍他福林对胰岛素抵抗HepG2细胞模型的作用及其初步机制[J].中国新药杂志,2008,17(12):1026-1029. 被引量:10
  • 9Xie W D, Wang W, S extracts of Ananasco sensitivity in rats Biochemistry and Physi u H, et al. Effect of ethanolic mosus L. leaves on insulin and HepG2[J]. Comparative ology, 2006, 143: 429-435.
  • 10Collison M, Campbell I W, Salt I P, et al. Sex hormo- nes induce insulin resistance in 3T3-L1 adipocytes by reducing cellular content of IRS proteins[J]. Diabeto- logia, 2000, 43 (11): 1374-1380.

二级参考文献16

  • 1陈秋,夏永鹏,邱宗荫.吡格列酮对胰岛素抵抗HepG2细胞模型的药理学评价[J].中国药理学通报,2006,22(2):248-251. 被引量:33
  • 2Gurnell M,Savage DB,Chatterjee VK et al.The metabolic syndrome:Peroxisome proliferator-activated receptor gamma and its therapeutic modulation[J].J Clin Endocrinol Metab,2003,88(6):2412-21.
  • 3Tadayyon M,Smith SA.Insulin sensitisation in the treatment of Type diabetes[J].Expert Opin Investig Drugs,2003,12(3):307-24.
  • 4Melin B,Cherqui G,Blivet MJ et al.Dual effect of metformin in cultured rat hepatocytes:potentiation of insulin action and prevention of insulin-induced insulin resistance[J].Metabolism,1990,39:1089.
  • 5Arakawa K,Ishihara T,Auto M et al.Action of novel antidiabetic thiazolidinedione,T-174,in animals of non-insulin-dependent diabetes mellitus(NIDDM) and in cultured muscle cells[J].Br J Pharmacol,1998,125:429-36.
  • 6Senn JJ,Klover PJ,Nowak IA et al.Interleukin-6 induces cellular insulin resistance in hepatocytes[J].Diabetes,2002,51(12):3391-9
  • 7Bernal MC,Weng S,Finck BN et al.Dexamethasone induction of hypertension and diabetes is PPAR-alpha dependent in LDL receptor-null mice[J].Nat Med,2003,9(8):1069-75.
  • 8Camp HS.Thiazolidinediones in diabetes:Current status and future outlook[J].Curr Opin Investig Drugs,2003,4(4):406-11.
  • 9Santure M,Pitre M,Nadeau A et al.Effect of troglitazone on vascular and glucose metabolic actions of insulin in high-sucrose-fed rats[J].Metabolism,2003,52(8):978-86.
  • 10Julia A,Barman B,Greg L.Rosiglitazone[J].Drugs,1999,57:921-7.

共引文献38

同被引文献37

引证文献3

二级引证文献20

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部